NEW YORK, Jan. 5, 2021 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that it has entered into a definitive securities purchase agreement in conne …
(Orginal – Story lesen…)
Business News
NEW YORK, Jan. 5, 2021 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that it has entered into a definitive securities purchase agreement in conne …
(Orginal – Story lesen…)